Search Results - "Philippe, Laure"
-
1
Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm
Published in Haematologica (Roma) (01-11-2017)“…Blastic plasmacytoid dendritic cell neoplasm is an aggressive hematologic malignancy with a poor prognosis. No consensus regarding optimal treatment modalities…”
Get full text
Journal Article -
2
S226: EFFICACY OF ANTI‐PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
3
-
4
Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/T‐Cell lymphoma, nasal type: A French study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC)
Published in American journal of hematology (01-07-2021)“…We evaluated the outcome of 65 French patients with Extranodal NK/T‐cell lymphoma, nasal type (ENKTL) undergoing hematopoietic stem cell transplantation (HSCT)…”
Get full text
Journal Article -
5
BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR‐T cell cytotoxicity
Published in EJHaem (01-02-2021)“…Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy with poor prognosis and no treatment consensus. Combining chemotherapy…”
Get full text
Journal Article -
6
Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with non‐Hodgkin lymphoma treated with B‐cell depleting immunotherapy
Published in American journal of hematology (01-08-2021)“…Prolonged Covid‐19 is an emerging issue for patients with lymphoma or immune deficiency. We aimed to examine prolonged length of in‐hospital stay (LOS) due to…”
Get full text
Journal Article -
7
LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis
Published in Blood (08-12-2016)“…Blastic plasmacytoid dendritic cell (PDC) neoplasm (BPDCN) is an aggressive hematological malignancy with a poor prognosis that derives from PDCs. No consensus…”
Get full text
Journal Article -
8
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis
Published in Leukemia (01-07-2023)“…Natural killer/T-cell lymphomas (NKTCL) represent rare and aggressive lymphoid malignancies. Patients (pts) with relapsed/refractory disease after Asparaginase…”
Get full text
Journal Article -
9
Quel recul sur la sécurité du romiplostim dans les syndromes myélodysplasiques ?
Published in Hématologie (01-07-2017)Get full text
Journal Article -
10
-
11
Du nouveau dans le traitement du lymphome de la zone marginale : ibrutinib en rechute post-rituximab
Published in Hématologie (01-05-2017)Get full text
Journal Article -
12
Pomalidomide dans les syndromes myéloprolifératifs avec myélofibrose : la déception en phase III
Published in Hématologie (01-05-2017)Get full text
Journal Article -
13
Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma
Published in Cancer research (Chicago, Ill.) (02-07-2024)“…Extranodal NK/T-cell lymphoma (ENKTCL) is an Epstein-Barr virus (EBV)-related neoplasm with male dominance and a poor prognosis. A better understanding of the…”
Get full text
Journal Article -
14
Daratumumab en combinaison dans le myélome multiple en rechute : après Castor, voici Pollux
Published in Hématologie (01-11-2016)Get full text
Journal Article -
15
-
16
Un traitement de maintenance par rituximab dans la leucémie lymphoïde chronique ? Résultats de l’étude CCL8
Published in Hématologie (01-07-2016)Get full text
Journal Article -
17
Abstract S09-02: High incidence of persistent COVID-19 among patients with lymphoma treated with B-cell depleting immunotherapy
Published in Clinical cancer research (15-03-2021)“…Abstract Introduction Treatment of B-lineage lymphoma with B-cell depleting immunotherapy causes B-cell aplasia and impairs immune response. Case studies have…”
Get full text
Journal Article -
18
Tentative d’optimisation de la prise en charge des lymphomes T périphériques en première ligne : les résultats modestes du COEP associé au pralatrexate
Published in Hématologie (01-03-2016)Get full text
Journal Article -
19
Association ibrutinib et rituximab : intérêt d’un traitement chemotherapy-free dans le lymphome à cellules du manteau en rechute ou réfractaire
Published in Hématologie (01-01-2016)Get full text
Journal Article -
20
Frequent Alterations of Driver Genes in Chromosome X and Their Clinical Relevance in Extranodal NK/T-Cell Lymphoma
Published in BLOOD (15-11-2022)Get full text
Journal Article Conference Proceeding